Published in Virology on February 01, 1982
Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J Virol (1990) 4.32
Poxvirus pathogenesis. Microbiol Rev (1991) 3.54
A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J Virol (1987) 2.53
Rotavirus nonstructural glycoprotein NSP4 alters plasma membrane permeability in mammalian cells. J Virol (1997) 1.14
Overexpression of the vaccinia virus A38L integral membrane protein promotes Ca2+ influx into infected cells. J Virol (1996) 1.11
Inhibitors of poliovirus uncoating efficiently block the early membrane permeabilization induced by virus particles. J Virol (1991) 0.92
Vaccinia virus induces Ca2+-independent cell-matrix adhesion during the motile phase of infection. J Virol (1998) 0.86
Translocation of alpha-sarcin across the lipid bilayer of asolectin vesicles. Biochem J (1993) 0.83
Membrane-bound complement regulatory activity is decreased on vaccinia virus-infected cells. Clin Exp Immunol (1994) 0.79
Hirsutellin A: A Paradigmatic Example of the Insecticidal Function of Fungal Ribotoxins. Insects (2013) 0.76
Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev (2006) 4.13
The dsRNA protein kinase PKR: virus and cell control. Biochimie (2007) 3.67
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. J Virol (1985) 3.06
Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J Immunol Methods (1995) 2.82
The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology (1994) 2.78
Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis (2000) 2.63
A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J Virol (1987) 2.53
Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol (2000) 2.48
Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci U S A (1993) 2.44
The trichodermin group of antibiotics, inhibitors of peptide bond formation by eukaryotic ribosomes. Biochim Biophys Acta (1973) 2.36
Poliovirus protein 2C has ATPase and GTPase activities. J Biol Chem (1993) 2.32
Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein. Virology (1990) 2.27
Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A. Virology (1992) 2.18
Sodium ions and the shut-off of host cell protein synthesis by picornaviruses. Nature (1977) 2.12
Involvement of the vacuolar H(+)-ATPase in animal virus entry. J Gen Virol (1994) 2.06
Entry of poliovirus into cells does not require a low-pH step. J Virol (1993) 2.05
Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. Virology (1984) 2.04
Viral infection permeabilizes mammalian cells to protein toxins. Cell (1980) 2.04
Induction of membrane proliferation by poliovirus proteins 2C and 2BC. Biochem Biophys Res Commun (1995) 2.03
Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J Virol (1997) 2.00
Vaccinia virus 15-kilodalton (A14L) protein is essential for assembly and attachment of viral crescents to virosomes. J Virol (1998) 1.91
Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J Virol (1995) 1.89
Phospholipid biosynthesis and poliovirus genome replication, two coupled phenomena. EMBO J (1990) 1.88
Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein. J Virol (1987) 1.87
Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J Virol (1992) 1.86
The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene. J Virol (1993) 1.86
Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc Natl Acad Sci U S A (1988) 1.78
Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells. J Virol (1995) 1.77
Poliovirus protein 2C contains two regions involved in RNA binding activity. J Biol Chem (1995) 1.74
Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology (1998) 1.73
Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J Virol (1989) 1.71
A human virus protein, poliovirus protein 2BC, induces membrane proliferation and blocks the exocytic pathway in the yeast Saccharomyces cerevisiae. EMBO J (1995) 1.69
Early virus protein synthesis in vaccinia virus-infected cells. J Gen Virol (1973) 1.63
Interferon inhibits viral protein synthesis in L cells infected with vaccinia virus. Nature (1972) 1.63
Vaccinia virus membrane proteins p8 and p16 are cotranslationally inserted into the rough endoplasmic reticulum and retained in the intermediate compartment. J Virol (1997) 1.60
A 14K envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus. Virology (1987) 1.59
Lack of direct correlation between p220 cleavage and the shut-off of host translation after poliovirus infection. Virology (1992) 1.57
Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Mol Cell Biol (1999) 1.54
Ribosome inactivation by the toxic lectins abrin and ricin. Kinetics of the enzymic activity of the toxin A-chains. Eur J Biochem (1975) 1.54
Structural and functional characterization of a cell surface binding protein of vaccinia virus. J Biol Chem (1990) 1.54
Membrane permeabilization by poliovirus proteins 2B and 2BC. J Biol Chem (1996) 1.51
Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus. J Virol (1995) 1.47
Membrane leakiness after viral infection and a new approach to the development of antiviral agents. Nature (1978) 1.46
Vagal system involvement in changes in small bowel motility during restraint stress: an experimental study in the dog. Br J Surg (1993) 1.46
Generation of a dominant 8-MDa deletion at the left terminus of vaccinia virus DNA. Proc Natl Acad Sci U S A (1985) 1.41
Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Mol Cell Biol (1996) 1.40
Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cell Immunol (1996) 1.38
A vaccinia virus core protein, p39, is membrane associated. J Virol (1996) 1.37
Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. J Virol (1997) 1.37
Expression of poliovirus nonstructural proteins in Escherichia coli cells. Modification of membrane permeability induced by 2B and 3A. J Biol Chem (1992) 1.35
Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology (1997) 1.35
Molecular cloning, encoding sequence, and expression of vaccinia virus nucleic acid-dependent nucleoside triphosphatase gene. Proc Natl Acad Sci U S A (1986) 1.31
Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus. Virology (1997) 1.31
Polysaccharides as antiviral agents: antiviral activity of carrageenan. Antimicrob Agents Chemother (1987) 1.31
Proteins are cointernalized with virion particles during early infection. Virology (1987) 1.30
Isolation and characterization of attenuated mutants of vaccinia virus. Virology (1987) 1.30
HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation. Proc Natl Acad Sci U S A (2001) 1.30
Efficient cleavage of p220 by poliovirus 2Apro expression in mammalian cells: effects on vaccinia virus. Biochem Biophys Res Commun (1995) 1.29
The synthesis of encephalomyocarditis virus polypeptides in infected L-cells and cell-free systems. Eur J Biochem (1974) 1.28
Monensin and nigericin prevent the inhibition of host translation by poliovirus, without affecting p220 cleavage. J Virol (1995) 1.28
The inhibition of cell functions after viral infection. A proposed general mechanism. FEBS Lett (1977) 1.27
The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology (1997) 1.26
Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence. J Virol (1987) 1.25
Studies on the mechanism of entry of vaccinia virus in animal cells. Arch Virol (1987) 1.25
The entry of reovirus into L cells is dependent on vacuolar proton-ATPase activity. J Virol (1996) 1.24
Structure of vaccinia DNA: analysis of the viral genome by restriction endonucleases. Virology (1978) 1.23
Genetic analysis of poliovirus protein 3A: characterization of a non-cytopathic mutant virus defective in killing Vero cells. J Gen Virol (1998) 1.22
Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector. J Virol (2000) 1.22
3-Methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis. Virology (1986) 1.22
The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals. J Virol (1991) 1.22
Defective vaccinia virus particles in interferon-treated infected cells. Virology (1984) 1.21
Semliki Forest virus 6K protein modifies membrane permeability after inducible expression in Escherichia coli cells. J Biol Chem (1994) 1.21
Inducible expression of the vaccinia virus A17L gene provides a synchronized system to monitor sorting of viral proteins during morphogenesis. J Virol (1996) 1.20
Modification of membrane permeability induced by animal viruses early in infection. Virology (1981) 1.19
Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus in vitro. J Virol (1987) 1.18
Enhanced intracellular calcium concentration during poliovirus infection. J Virol (1995) 1.18
Structural and functional properties of the 14-kDa envelope protein of vaccinia virus synthesized in Escherichia coli. J Biol Chem (1990) 1.18
Synthesis of Semliki Forest virus RNA requires continuous lipid synthesis. Virology (1991) 1.17
Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus. J Virol (1999) 1.17
The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus. Virology (1993) 1.16
Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice. Proc Natl Acad Sci U S A (1998) 1.16
The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors. Oncogene (2000) 1.15
Initiation of the polypeptide chain by reticulocyte cell-free systems. Survey of different inhibitors of translation. Eur J Biochem (1976) 1.15
Replication of vaccinia DNA in mouse L cells. I. In vivo DNA synthesis. Virology (1977) 1.14
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses. Proc Natl Acad Sci U S A (1989) 1.14
Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology (1997) 1.14
Poliovirus protease 3C(pro) kills cells by apoptosis. Virology (2000) 1.13
Vaccinia virus transcription: hybridization of mRNA to restriction fragments of vaccinia DNA. Virology (1978) 1.12
Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus. J Virol (1987) 1.12
Studies on the mechanisms of vaccinia virus cytopathic effects. II. Early cell rounding is associated with virus polypeptide synthesis. J Gen Virol (1978) 1.12
Tuberculosis transmission risk and infection control in a hospital emergency department in Lima, Peru. Int J Tuberc Lung Dis (2010) 1.11
The interferon-induced double-stranded RNA-activated human p68 protein kinase potently inhibits protein synthesis in cultured cells. Virology (1993) 1.10
African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death. Virology (1996) 1.10
SIRT1 stabilizes PML promoting its sumoylation. Cell Death Differ (2010) 1.10
Thionins: plant peptides that modify membrane permeability in cultured mammalian cells. Eur J Biochem (1981) 1.10
Insertional inactivation of the vaccinia virus 32-kilodalton gene is associated with attenuation in mice and reduction of viral gene expression in polarized epithelial cells. J Virol (1992) 1.10
Activation of the double-stranded RNA (dsRNA)-activated human protein kinase in vivo in the absence of its dsRNA binding domain. Proc Natl Acad Sci U S A (1994) 1.10